Skip to content

Neuronetics STIM Interest coverage

Interest coverage at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
4.3×+3.8×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-2.5×+0.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
101×+77.4×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-55.8×
Myriad Genetics logo
Myriad GeneticsMYGN
-28.2×-6.5×
LivaNova logo
LivaNovaLIVN
4.5×+2.0×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on trailing twelve months.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's interest coverage?
Neuronetics (STIM) reported interest coverage of -3.4× in Q1 2026.
How has Neuronetics's interest coverage changed year-over-year?
Neuronetics's interest coverage increased by 36.0% year-over-year, from -5.2× to -3.4×.
What is the long-term trend for Neuronetics's interest coverage?
Over 5 years (2020 to 2025), Neuronetics's interest coverage has grown at a -5.4% compound annual growth rate (CAGR), from -4.9× to -3.7×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.